Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial.

Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial. Am Heart J. 2018 02; 196:28-35.

View in: PubMed

subject areas

Acute Coronary Syndrome
Aged
Coronary Angiography
Disease Progression
Double-Blind Method
Electrocardiography
Female
Follow-Up Studies
Humans
Internationality
Male
Middle Aged
Myocardial Ischemia
Non-ST Elevated Myocardial Infarction
Receptors, Thrombin
Risk Assessment
Severity of Illness Index
Survival Analysis
Treatment Outcome

authors with profiles

Robert Harrington